These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23394907)

  • 1. Application for tacrolimus ointment in treating refractory inflammatory ocular surface diseases.
    Lee YJ; Kim SW; Seo KY
    Am J Ophthalmol; 2013 May; 155(5):804-13. PubMed ID: 23394907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases.
    Miyazaki D; Tominaga T; Kakimaru-Hasegawa A; Nagata Y; Hasegawa J; Inoue Y
    Ophthalmology; 2008 Jun; 115(6):988-992.e5. PubMed ID: 17900694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term result of maintenance treatment with tacrolimus ointment in chronic ocular graft-versus-host disease.
    Jung JW; Lee YJ; Yoon SC; Kim TI; Kim EK; Seo KY
    Am J Ophthalmol; 2015 Mar; 159(3):519-27.e1. PubMed ID: 25498356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study.
    Attas-Fox L; Barkana Y; Iskhakov V; Rayvich S; Gerber Y; Morad Y; Avni I; Zadok D
    Curr Eye Res; 2008 Jul; 33(7):545-9. PubMed ID: 18600486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis.
    Kymionis GD; Goldman D; Ide T; Yoo SH
    Cornea; 2008 Feb; 27(2):228-9. PubMed ID: 18216583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis.
    Al-Amri AM
    Am J Ophthalmol; 2014 Feb; 157(2):280-6. PubMed ID: 24439439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of refractory atopic blepharoconjunctivitis with topical tacrolimus 0.03% dermatologic ointment.
    Sakarya Y; Sakarya R
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):94-6. PubMed ID: 22103968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis.
    Liu FY; Liu HY; Chu HS; Chen WL; Hu FR; Wang IJ
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):967-974. PubMed ID: 30852635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis.
    Ryu EH; Kim JM; Laddha PM; Chung ES; Chung TY
    Korean J Ophthalmol; 2012 Aug; 26(4):241-7. PubMed ID: 22870021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus ointment 0.03% for treatment of refractory childhood phlyctenular keratoconjunctivitis.
    Kymionis GD; Kankariya VP; Kontadakis GA
    Cornea; 2012 Aug; 31(8):950-2. PubMed ID: 22525784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis.
    Tzu JH; Utine CA; Stern ME; Akpek EK
    Cornea; 2012 Jun; 31(6):649-54. PubMed ID: 22378107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
    Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
    Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
    Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of a novel protocol of pulsed intravenous cyclophosphamide for recalcitrant or severe ocular inflammatory disease.
    Suelves AM; Arcinue CA; González-Martín JM; Kruh JN; Foster CS
    Ophthalmology; 2013 Jun; 120(6):1201-9. PubMed ID: 23601800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical tacrolimus ointment for the treatment of lichen sclerosus, comparing genital and extragenital involvement.
    Kim GW; Park HJ; Kim HS; Kim SH; Ko HC; Kim BS; Kim MB
    J Dermatol; 2012 Feb; 39(2):145-50. PubMed ID: 22044240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Topical Fk506 in inflammatory corneal and conjunctival diseases. A pilot study].
    Reinhard T; Reis A; Mayweg S; Oberhuber H; Mathis G; Sundmacher R
    Klin Monbl Augenheilkd; 2002 Mar; 219(3):125-31. PubMed ID: 11987039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical tacrolimus treatment for chronic dermatitis of the ear.
    Harth W; Caffier PP; Mayelzadeh B; Haupt H; Sedlmaier B; Richard G
    Eur J Dermatol; 2007; 17(5):405-11. PubMed ID: 17673384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders.
    Joseph MA; Kaufman HE; Insler M
    Cornea; 2005 May; 24(4):417-20. PubMed ID: 15829797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
    Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.